STAT3 and glioblastoma: Of note, increased expression of IL-6, IL-6 receptor or activated (phosphorylated) STAT3 correlated with poor survival of glioblastoma patients, and so does loss of the IL-6 negative regulator SOCS3 [149,150,151].